The Global Trial Accelerators™ podcast (formerly known as LATAM Medtech Leaders) delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.
🚀 First-in-Human Clinical Trials 40% Faster & 30% Lower Cost | MedTech & Biopharma Startups Struggling with endless delays and skyrocketing costs for your first-in-human studies? Discover the Latin American Advantage — a proven strategy that's transforming how innovative MedTech and biopharma comp…
In this episode, we’re joined by Alfonso, CEO at Leon Research and Managing Board Member at AICROS, to dive into leadership, growth, and innovation in clinical research. With 14 years of experience in executive and managerial roles—including over a decade in clinical investigation—Alfonso brings a…
In this episode, we welcome Alfonso , CEO at Leon Research and Managing Board Member and Marketing Director at AICROS , for an in-depth conversation on leadership, clinical research, and business development in the pharmaceut...
In this episode of Global Trial Accelerators, we sit down with Justin Chickles, CEO and co-founder of Glycyx Therapeutics, a clinical-stage biotech company taking on a hidden threat to cancer immunotherapy success: opioids. With over two decades of leadership across therapeutics, diagnostics, and …
In this episode, we welcome Steven Collens, CEO of MATTER, one of the world’s leading healthcare incubators and innovation hubs. Under Steven’s leadership, MATTER has supported more than 1,000 healthcare startups, helping innovators move faster, collaborate more effectively, and significantly impro…
This episode features Steven Collens, CEO of MATTER, a premier healthcare incubator and innovation hub that has supported over 1,000 healthcare startups. MATTER helps entrepreneurs and organizations innovate faster and more efficiently while increasing the likelihood of long-term success. Founde…
Welcome back to the blog, fellow explorers of innovation! In our latest podcast episode, we had the incredible opportunity to sit down with Matteo Talotta, a true visionary in the field of clinical solutions. Our conversation was so rich with insigh…
Welcome back to the podcast blog! In our latest episode, we had the immense pleasure of speaking with Sonal Pendharkar Kulkarni, the brilliant Co-founder and Chief Scientific Officer at Uvisa Health. Her insights were truly illuminating, and today, …
In today's fast-paced business environment, building a high-performing team is paramount to achieving sustainable success. Nowhere is this truer than in the demanding world of private equity, where the stakes are high and the pressure to deliver exc…
CEO, bioaccess®
Julio G. Martinez-Clark, CEO of bioaccess®, has spent over a decade dismantling barriers to Medtech, Biopharma, and Radiopharma innovation by positioning Latin America, Eastern Europe (the Balkans), and Australia as global leaders in clinical research. His work challenges entrenched perceptions of the region, transforms healthcare access for underserved populations, and reimagines how medical innovations reach commercialization. Through bioaccess®, Julio has created a blueprint for cost-effective, ethically rigorous clinical trials that accelerate time-to-market while elevating local communities.
Business Development Director, bioaccess®
Jesus E. Moreno is a business development director who provides efficient and reliable clinical research services in Latin America. With a passion for driving innovation in the healthcare sector, Jesus leverages his bilingual biomedical engineering background and his understanding of the unique challenges that Medtech startups face to provide valuable support and deliver accelerated clinical study results. Jesus profoundly understands the critical role that reliable and streamlined clinical research plays in the success of Medtech startups. He firmly believes that by offering cost-effective solutions without compromising quality, Medtech startups can achieve their clinical goals faster and make a meaningful impact in the healthcare industry. Jesus is passionate about supporting Medtech startups in their journey towards bringing innovative medical technologies to market. Jesus possesses the technical expertise to understand the complexities of medical devices and technologies. This knowledge enables him to identify tailored solutions that meet the specific needs of Medtech startups. Jesus has a bachelor's degree in biomedical engineering and a master's degree in electronics engineering.